The accuracy of antibiotic resistance determination from Enterococcus faecium genomes for diagnostic purposes.
Eli Lilly to acquire Versanis in heated race for weight loss drugs
Eli Lilly said Friday it will acquire Versanis Bio, a private company developing an obesity drug that specifically targets fat mass, as the race among